EpimAb Biotherapeutics Raises $25M In Series A Financing From International Consortium To Advance Pipeline Of Novel Bispecific Antibodies Post author:Sam Post published:April 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Johnson & Johnson CEO Backpedals and Quits Right Before Disbands Council August 16, 2017 Dova Pharma Announces Pricing Of Initial Public Offering June 28, 2017 Antibe Therapeutics Announces Filing Of Final Short Form Prospectus June 14, 2017